Of the seven patients with biallelic FANCA loss, five also exhibited BRCA1 biallelic loss, suggesting the need for further research to clarify the role of FANCA promoter methylation in HRD. The gene discussed is FANCA; the disease is hypoparathyroidism-retardation-dysmorphism syndrome.